8 years ago

Stent Tek Secures Series A Funding for Kidney Dialysis Innovation

  • Stent Tek, a London-based medical device company, closed a Series A funding round of undisclosed amount

  • The company will use the funds to advance its ePATH AVF system, which is a novel catheter-based system for creating vascular access fistulas in haemodialysis patients

  • Stent Tek previously received £1.2m in grant funding from the National Institute of Health Research (NIHR), Innovate UK, and the Royal Academy of Engineering Enterprise Hub

  • The company anticipates the ePATH AVF catheter system will complete pre-clinical trials by Q4 2017.

      • ProblemHealthcare

      "making access to haemodialysis for kidney failure safer and more efficient for 2.8 million patients globally"

      Solution

      "developing a novel catheter-based system (ePATH AVF) for creating a vascular access fistula in haemodialysis patients at the wrist level"

      Covered on